Mark Simon's journey into cancer research began in 2004, building on a foundation of plant-based nutrition, holistic health, and natural medicine studies that started in 1982. Driven by a firm belief that nontoxic, nutritional alternatives to surgery, radiation, and chemotherapy can support cancer recovery, Mark established NORI in 2011. Under his leadership, NORI has grown from an independent research organization into a globally accessible cancer support network, helping patients with breast, prostate, thyroid, and advanced cancers worldwide. His work on the NORI Protocol — centered on methionine restriction and proprietary nutraceuticals — has supported remarkable recovery outcomes, including documented Stage IV remissions.